As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, founder and CEO of Within3, and Jason Smith, the company’s chief technology officer for AI and analytics, told Fierce. They emphasized shrinking launch timelines, the growing role of AI in surfacing actionable insights, and the need to break down internal silos to improve cross-functional alignment.
Hill and Smith also stressed managing disinformation, optimizing workflows and embracing automation to reduce manual overhead, freeing resources to focus on patients and market understanding. They said leaders should ensure teams are never uninformed and remain open to new tools and approaches.
The editorial staff had no role in this post's creation.